GoKawiilBiotech firms expand pet longevity drugs and $50,000 cloning services
Companies including Loyal are testing longevity drugs for dogs, with one trial involving roughly 1,300 pet dogs in the US targeting metabolic health, alongside other firms developing treatments for age-related conditions like obesity and osteoarthritis, and even cat longevity medicines. Separately, Viagen Pets offers pet cloning for $50,000, producing a genetic twin rather than an exact replica by implanting a pet's DNA into a donor egg and growing it in a surrogate.